COMPANIES selling cannabis based products in the UK have been told to remove them from the market within 28 days, after a review by the Medicines and Healthcare Products Regulatory Agency (MHRA) determined that they were medicinal products.
Campaigners for cannabis law reform (CLEAR) welcomed the recognition that cannabidiol (CBD) had medicinal properties but warned that the MHRA's action would deprive thousands of users of a product they relied on.
They said that while it was a good thing in the long run, it was impossible to obtain marketing authorisation in the timescale given and may never be possible given the high costs of clinical trials and lack of patent protection.
Visit www.bmj.com for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Oct 16
